The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
The Polycomb complex PRC2 and its mark in life
Open accessAbstract
Polycomb group proteins maintain the gene-expression pattern of different cells that is set during early development by regulating chromatin structure. In mammals, two main Polycomb group complexes exist - Polycomb repressive complex 1 (PRC1) and 2 (PRC2). PRC1 compacts chromatin and catalyses the monoubiquitylation of histone H2A. PRC2 also contributes to chromatin compaction, and catalyses the methylation of histone H3 at lysine 27. PRC2 is involved in various biological processes, including differentiation, maintaining cell identity and proliferation, and stem-cell plasticity. Recent studies of PRC2 have expanded our perspectives on its function and regulation, and uncovered a role for non-coding RNA in the recruitment of PRC2 to target genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“That said, we do not wish to imply that DNA methylation is the only epigenetic mark involved in this process. It likely involves other transcription factors and epigenetic modifications, such as the PRC2 complex and H3K27me3, both of which are involved in maintaining stem cell plasticity and are associated with DNAm clock sites4,49,50.”
From Reprogramming to recover youthful epigenetic information and restore vision (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“EZH2 catalyzes nucleosome compaction via H3K27 trimethylation11”
From Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens (2021) · cites this paper as [11]
In the citing paper
“The suppression of clearance genes in striatal microglia is governed by Polycomb repressive complex 2 (PRC2), which catalyzes the repressive chromatin modification histone H3 lysine 27 tri-methylation (H3K27me3)16.”
From Epigenetic regulation of brain region-specific microglia clearance activity (2018) · cites this paper as [16]
In the citing paper
“H3K27me3 is mediated by PRC2, which has a well-established role in the regulation of cell differentiation during development16.”
From Epigenetic regulation of brain region-specific microglia clearance activity (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X. H., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,246
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
A gene complex controlling segmentation in Drosophila
Lewis, E. B. (1978) · Nature · doi:10.1038/276565a0 · Cited by 3,813
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290 · cited 1×
“Long ncRNA could also promote PRC2 binding in trans as shown for the RNA HOTAI”
BackgroundKhalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., Thomas, K., Presser, A., Bernstein, B. E., van Oudenaarden, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904715106 · Cited by 2,872
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,568
Genome-scale DNA methylation maps of pluripotent and differentiated cells
Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B. E., Nusbaum, C., Jaffe, D. B., et al. (2008) · Nature · doi:10.1038/nature07107 · Cited by 2,536
Flagged first, then by citations
Research works printed but not linked: 1
- Lewis, P. Pc: Polycomb. Drosoph. Inf. Ser. 21, 69 (1949).
Cited by
Sorted by citations
Items 601–700 of 1,009
Dudakovic, A., Camilleri, E. T., Paradise, C. R., Samsonraj, R. M., Gluscevic, M., Paggi, C. A., Begun, D. L., Khani, F., Pichurin, O., Ahmed, F. S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002983 · Cited by 88
EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells
Zhao, Y., Wang, X., Wu, W., Long, H., Huang, J., Wang, Z., Li, T., Tang, S., Zhu, B., & Chen, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.039 · Cited by 91
Sidoli, S., Schwämmle, V., Ruminowicz, C., Hansen, T. A., Wu, X., Helin, K., & Jensen, O. N. (2014) · PROTEOMICS · doi:10.1002/pmic.201400084 · Cited by 87
Wang, W., Cohen, J. A., Wallrapp, A., Trieu, K. G., Barrios, J., Shao, F., Krishnamoorthy, N., Kuchroo, V. K., Jones, M. R., Fine, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.002 · Cited by 86
Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition
Kim, H. J., Cantor, H., & Cosmopoulos, K. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.08.010 · Cited by 88
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
Zhang, P., & Zhang, M. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00962-x · Cited by 91
Recruitment and Biological Consequences of Histone Modification of H3K27me3 and H3K9me3
Kim, J. H., & Kim, H. (2012) · ILAR Journal · doi:10.1093/ilar.53.3-4.232 · Cited by 94
Post-translational modifications of EZH2 in cancer
Li, Z., Li, M., Wang, D., Hou, P., Chen, X., Chu, S., Chai, D., Zheng, J., & Bai, J. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00505-0 · Cited by 87
Meta‐analysis of genome‐wide DNA methylation and integrative omics of age in human skeletal muscle
Voisin, S. A. C., Jacques, M., Landen, S., Harvey, N. R., Haupt, L. M., Griffiths, L. R., Gancheva, S., Ouni, M., Jähnert, M., Ashton, K. J., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12741 · Cited by 93
Targeting the enhancer of zeste homologue 2 in medulloblastoma
Alimova, I. N., Venkataraman, S., Harris, P. S., Márquez, V. E., Northcott, P. A., Dubuc, A. M., Taylor, M. D., Foreman, N. K., & Vibhakar, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27455 · Cited by 87
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma
Vo, B. T., Li, C., Morgan, M. A., Theurillat, I., Finkelstein, D., Wright, S., Hyle, J. W., Smith, S. M. C., Fan, Y., Wang, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.073 · Cited by 86
Lewandowski, S. L., Janardhan, H. P., & Trivedi, C. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684753 · Cited by 85
Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation
Zahnow, C. A., Topper, M. J., Stone, M. L., Stewart, T. M., Li, H., Baylin, S. B., & Casero, R. A. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.007 · Cited by 88
Zhang, Y., Yang, X., Gui, B., Xie, G., Zhang, D., Shang, Y., & Liang, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271064 · Cited by 89
Muratani, M., Deng, N., Ooi, W. F., Lin, S. J., Xing, M., Xu, C., Qamra, A., Tay, S. T., Malik, S., Wu, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5361 · Cited by 84
PRDM14: a unique regulator for pluripotency and epigenetic reprogramming
Nakaki, F., & Saitou, M. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.04.003 · Cited by 87
Digging deep into “dirty” drugs – modulation of the methylation machinery
Pleyer, L., & Greil, R. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.995379 · Cited by 84
“EZH2 is only active when it is associated with the other PRC2 core components: embryonic ectoderm development (EED), suppressor of zeste 12 homolog (SUZ12) and retinoblastoma binding protein 4 (RBBP4); (Kogure et al., 2013; Margueron & Reinberg, 2011) (Figure 2C).”
BackgroundMultifaceted role of EZH2 in breast and prostate tumorigenesis
Deb, G., Thakur, V. S., & Gupta, S. (2013) · Epigenetics · doi:10.4161/epi.24532 · Cited by 92
Jmjd3 Controls Mesodermal and Cardiovascular Differentiation of Embryonic Stem Cells
Ohtani, K., Zhao, C., Dobreva, G. D., Manavski, Y., Kluge, B., Braun, T. W., Rieger, M. A., Zeiher, A. M., & Dimmeler, S. (2013) · Circulation Research · doi:10.1161/circresaha.113.302035 · Cited by 87
Zapata, J. C., Campilongo, F., Barclay, R. A., DeMarino, C., Iglesias-Ussel, M. D., Kashanchi, F., & Romerio, F. (2017) · Virology · doi:10.1016/j.virol.2017.03.002 · Cited by 84
Lin, K., Rutter, J. C., Xie, A., Pardieu, B., Winn, E. T., Bello, R. D., Forget, A., Itzykson, R., Ahn, Y.-R., Dai, Z., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0590-9 · Cited by 88
Mangiante, L., Alcala, N., Sexton‐Oates, A., Genova, A. D., González-Pérez, A., Khandekar, A., Bergstrom, E. N., Kim, J., Liu, X., Blázquez‐Encinas, R., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01321-1 · Cited by 89
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Venkadakrishnan, V. B., Presser, A. G., Singh, R., Booker, M. A., Traphagen, N. A., Weng, K., Voss, N. C. E., Mahadevan, N. R., Mizuno, K., Puca, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51156-5 · Cited by 84
Posttranslational modifications of human histone H3: An update
Xu, Y., Du, J.-Y., & Lau, A. T. Y. (2014) · PROTEOMICS · doi:10.1002/pmic.201300435 · Cited by 89
Fang, C., Qiao, Y., Mun, S. H., Lee, M. J., Murata, K., Bae, S., Zhao, B., Park‐Min, K., & Ivashkiv, L. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501466 · Cited by 85
Li, X., Lin, Y., Yang, X., Wu, X., & He, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.150 · Cited by 83
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Hirukawa, A., Smith, H. W., Zuo, D., Dufour, C. R., Savage, P., Bertos, N., Johnson, R. M., Bui, T., Bourque, G., Basik, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04864-8 · Cited by 85
Wang, Y., Long, H., Yu, J., Dong, L., Wassef, M. A., Zhuo, B., Li, X., Zhao, J., Wang, M., Liu, C., et al. (2018) · BMC Biology · doi:10.1186/s12915-018-0568-6 · Cited by 81
Self-citationLncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential
Begolli, R., Sideris, N., & Giakountis, A. (2019) · Cancers · doi:10.3390/cancers11101524 · Cited by 90
Peng, X., Hu, Z., Zeng, L., Zhang, M., Xu, C., Lu, B., Tao, C., Chen, W., Hou, W., Cheng, K., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.09.003 · Cited by 87
The Properties of Long Noncoding RNAs That Regulate Chromatin
Rutenberg-Schoenberg, M., Sexton, A. N., & Simon, M. D. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-024939 · Cited by 86
Qiao, Y., Kang, K., Γιαννοπούλου, Ε., Fang, C., & Ivashkiv, L. B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.051 · Cited by 83
A non‐canonical function of Ezh2 preserves immune homeostasis
Vasanthakumar, A., Xu, D., Lun, A. T. L., Kueh, A. J., van Gisbergen, K. P. J. M., Iannarella, N., Li, X., Yu, L., Wang, D., Williams, B. R. G., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643237 · Cited by 86
Arbuckle, J. H., Gardina, P. J., Gordon, D. N., Hickman, H. D., Yewdell, J. W., Pierson, T. C., Myers, T. G., & Kristie, T. M. (2017) · mBio · doi:10.1128/mbio.01141-17 · Cited by 83
Targeting histone methyltransferase EZH2 as cancer treatment
Kondo, Y. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu054 · Cited by 82
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation
Li, J.-D., Xi, Y., Li, W., McCarthy, R. L., Stratton, S. A., Zou, W., Li, W., Dent, S., Jain, A. K., & Barton, M. C. (2017) · Oncogene · doi:10.1038/onc.2016.453 · Cited by 81
A Chemical Genetics Approach for the Functional Assessment of Novel Cancer Genes
Zhou, Q., Derti, A., Ruddy, D. A., Rakiec, D. P., Kao, I., Lira, M., Gibaja, V., Chan, H., Yang, Y., Min, J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2930 · Cited by 85
SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170
Rezazadeh, S., Yang, D. X., Tombline, G., Simon, M. A., Regan, S. P., Seluanov, A., & Gorbunova, V. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz528 · Cited by 82
Histone target selection within chromatin: an exemplary case of teamworkPreprint
Lalonde, M., Cheng, X., & Côté, J. (2014) · Genes & Development · doi:10.1101/gad.236331.113 · Cited by 85
Tiffen, J. C., Gunatilake, D., Gallagher, S. J., Gowrishankar, K., Heinemann, A., Cullinane, C. M., Dutton‐Regester, K., Pupo, G. M., Strbenac, D., Yang, J. Y. H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4809 · Cited by 81
Rickels, R. A., Hu, D., Collings, C. K., Woodfin, A. R., Piunti, A., Mohan, M., Herz, H., Kvon, E. Z., & Shilatifard, A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.018 · Cited by 82
Gaiti, F., Jindrich, K., Fernández-Valverde, S. L., Roper, K. E., Degnan, B. M., & Tanurdžić, M. (2017) · eLife · doi:10.7554/elife.22194 · Cited by 84
Tsuboi, M., Kishi, Y., Yokozeki, W., Koseki, H., Hirabayashi, Y., & Gotoh, Y. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.11.018 · Cited by 86
DNA methylation clocks for dogs and humans
Horvath, S., Lu, A. T.-H., Haghani, A., Zoller, J. A., Li, C. Z., Lim, A. R., Brooke, R. T., Raj, K., Armero, A. S., Dreger, D. L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120887119 · Cited by 85
Regulation of T Cell Differentiation and Function by EZH2
Karantanos, T., Chistofides, A., Barhdan, K., Li, L., & Boussiotis, V. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00172 · Cited by 81
Roles of H3K27me2 and H3K27me3 Examined during Fate Specification of Embryonic Stem Cells
Juan, A. H., Wang, S., Ko, K. D., Zare, H., Tsai, P.-F., Feng, X., Vivanco, K. O., Ascoli, A. M., Gutierrez-Cruz, G., Krebs, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.087 · Cited by 77
Youmans, D. T., Schmidt, J. C., & Cech, T. R. (2018) · Genes & Development · doi:10.1101/gad.311936.118 · Cited by 85
PRC 1 is taking the lead in P c G repression
Merini, W., & Calonje, M. (2015) · The Plant Journal · doi:10.1111/tpj.12818 · Cited by 83
Chromatin signature of widespread monoallelic expression
Nag, A., Savova, V., Fung, H.-L., Miron, A., Yuan, G., Zhang, K., & Gimelbrant, A. A. (2013) · eLife · doi:10.7554/elife.01256 · Cited by 78
Loss of H3K27me3 in meningiomas
Nassiri, F., Wang, J. Z., Singh, O., Karimi, S., Dalcourt, T., Ijad, N., Pirouzmand, N., Ng, H., Saladino, A., Pollo, B., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab036 · Cited by 80
Uncovering the role of genomic “dark matter” in human disease
Martin, L., & Chang, H. Y. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60020 · Cited by 80
Cutting Edge: Smad2 and Smad4 Regulate TGF-β–Mediated Il9 Gene Expression via EZH2 Displacement
Wang, A., Pan, D., Lee, Y., Martínez, G., Feng, X., & Dong, C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300433 · Cited by 87
Zhou, Y., Hartwig, B., James, G. V., Schneeberger, K., & Turck, F. (2015) · The Plant Cell · doi:10.1105/tpc.15.00787 · Cited by 77
Schwämmle, V., Sidoli, S., Ruminowicz, C., Wu, X., Lee, C.-F., Helin, K., & Jensen, O. N. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.054460 · Cited by 80
Tóth, Z., Papp, B., Brulois, K., Choi, Y. J., Gao, S., & Jung, J. U. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005878 · Cited by 80
de Lucas, M., Pu, L., Turco, G. M., Gaudinier, A., Morao, A. K., Harashima, H., Kim, D., Ron, M., Sugimoto, K., Roudier, F., et al. (2016) · The Plant Cell · doi:10.1105/tpc.15.00744 · Cited by 84
Cancer: pathological nuclear reprogramming?
Goding, C. R., Pei, D., & Lü, X. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3781 · Cited by 82
Schwämmle, V., Aspalter, C.-M., Sidoli, S., & Jensen, O. N. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o113.036335 · Cited by 79
Kim, M., Yang, D., Kim, M., Kim, S., Kim, D., & Kang, S. (2017) · Scientific Reports · doi:10.1038/srep39804 · Cited by 82
Li, F., Zeng, Z., Xing, S., Gullicksrud, J. A., Shan, Q., Choi, J., Badovinac, V. P., Crotty, S., Peng, W., & Xue, H. (2018) · Nature Communications · doi:10.1038/s41467-018-07853-z · Cited by 79
Polycomb repressive 2 complex—Molecular mechanisms of function
Kouznetsova, V. L., Tchekanov, A., Li, X., Yan, X., & Tsigelny, I. F. (2019) · Protein Science · doi:10.1002/pro.3647 · Cited by 82
LncRNA HOTAIR: A Potential Prognostic Factor and Therapeutic Target in Human Cancers
Xin, X., Li, Q., Fang, J., & Zhao, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.679244 · Cited by 79
Kim, T. W., Kang, B.-H., Jang, H., Kwak, S., Shin, J., Kim, H., Lee, S.-E., Lee, S.-M., Lee, J., Kim, J.-H., et al. (2015) · Stem Cells · doi:10.1002/stem.2046 · Cited by 79
Lhuillier‐Akakpo, M., Frapporti, A., Wilkes, C. D., Matelot, M., Vervoort, M., Sperling, L., & Duharcourt, S. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004665 · Cited by 86
Centromeric and ectopic assembly of CENP-A chromatin in health and cancer: old marks and new tracks
Sharma, A. B., Dimitrov, S. I., Hamiche, A., & Dyck, E. V. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1298 · Cited by 82
Structure, mechanism, and regulation of polycomb-repressive complex 2
Moritz, L., & Trievel, R. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.800367 · Cited by 84
Cyrus, S., Burkardt, D. D., Weaver, D. D., & Gibson, W. T. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31754 · Cited by 78
The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis
Zhao, F., Xie, X., Tan, X., Yu, H., Tian, M., Lv, H., Qin, C., Qi, J., & Zhu, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691766 · Cited by 86
Non‐coding RNAs and EZH2 interactions in cancer: Long and short tales from the transcriptome
Benetatos, L., Voulgaris, E., Vartholomatos, G., & Hatzimichael, E. C. (2012) · International Journal of Cancer · doi:10.1002/ijc.27859 · Cited by 78
The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
Li, Z., Wang, Y., Qiu, J., Li, Q., Yuan, C., Zhang, W., Wang, D., Ye, J., Jiang, H., Yang, J., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1503 · Cited by 79
Deciphering the Epigenetic Code of Cardiac Myocyte Transcription
Preißl, S., Schwaderer, M., Raulf, A., Hesse, M., Grüning, B. A., Köbele, C., Backofen, R., Fleischmann, B. K., Hein, L., & Gilsbach, R. (2015) · Circulation Research · doi:10.1161/circresaha.115.306337 · Cited by 75
Rojas, A. P., Aguilar, R., Henríquez, B., Lian, J. B., Stein, J. L., Stein, G. S., van Wijnen, A. J., van Zundert, B., Allende, M. L., & Montecino, M. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657825 · Cited by 78
Oliviero, G., Brien, G. L., Waston, A., Streubel, G., Jerman, E., Andrews, D. C., Doyle, B., Munawar, N., Wynne, K. J., Crean, J. K. G., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.062240 · Cited by 89
EZH2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis
Zhao, Y., Ding, L., Wang, D., Ye, Z., He, Y., Ma, L., Zhu, R., Pan, Y., Wu, Q., Pang, K., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201899599 · Cited by 81
Non-canonical functions of the DNA methylome in gene regulation
Reddington, J. P., Pennings, S., & Meehan, R. R. (2013) · Biochemical Journal · doi:10.1042/bj20121585 · Cited by 81
Mikulski, P., Hohenstatt, M. L., Farrona, S., Smaczniak, C., Stahl, Y., Kalyanikrishna, Kaufmann, K., Angenent, G. C., & Schubert, D. (2019) · The Plant Cell · doi:10.1105/tpc.18.00663 · Cited by 77
PRC1 marks the difference in plant PcG repression.
Calonje, M. (2014) · Molecular Plant · doi:10.1093/mp/sst150 · Cited by 77
LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII
Shao, M., Chen, G., Lv, F., Liu, Y., Tian, H., Tao, R. N., Jiang, R., Zhang, W., & Zhuo, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17735 · Cited by 75
Wang, L., Xu, Z., Khawar, M. B., Liu, C., & Li, W. (2017) · Reproduction · doi:10.1530/rep-17-0153 · Cited by 78
YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators
Hoxha, S., Shepard, A., Troutman, S. A., Diao, H., Doherty, J. R., Janiszewska, M., Witwicki, R. M., Pipkin, M. E., Ja, W. W., Kareta, M. S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2415 · Cited by 76
Mammalian PRC1 Complexes: Compositional Complexity and Diverse Molecular Mechanisms
Geng, Z., & Gao, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228594 · Cited by 88
Das, P. P., Hendrix, D. A., Apostolou, E., Buchner, A. H., Canver, M. C., Beyaz, S., Ljuboja, D., Kuintzle, R., Kim, W., Karnik, R., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.053 · Cited by 74
Zhou, P., Wang, Z., Yuan, X., Zhou, C., Liu, L., Wan, X., Zhang, F., Ding, X., Wang, C., Xiong, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.439729 · Cited by 74
The emerging role of Polycomb repressors in the response to DNA damage
Vissers, J. H. A., van Lohuizen, M., & Citterio, E. (2012) · Journal of Cell Science · doi:10.1242/jcs.107375 · Cited by 81
Targeting epigenetic regulations in cancer
Ning, B., Li, W., Zhao, W., & Wang, R. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv116 · Cited by 77
Roche, J., Nasarre, P., Gemmill, R. M., Baldys, A., Pontis, J., Korch, C. T., Guilhot, J., Ait‐Si‐Ali, S., & Drabkin, H. A. (2013) · Cancers · doi:10.3390/cancers5020334 · Cited by 77
Ren, Z., Ahn, J. H., Liu, H., Tsai, Y., Bhanu, N. V., Koss, B. S., Allison, D. F., Ma, A., Storey, A. J., Wang, P., et al. (2019) · Blood · doi:10.1182/blood.2019000578 · Cited by 76
Kim, D. (2020) · Horticulture Environment and Biotechnology · doi:10.1007/s13580-019-00218-5 · Cited by 75
Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2
Dudakovic, A., Samsonraj, R. M., Paradise, C. R., Galeano‐Garces, C., Mol, M. O., Galeano, D., Zan, P., Galvan, M. L., Hevesi, M., Pichurin, O., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011685 · Cited by 75
Annotation of chromatin states in 66 complete mouse epigenomes during development
van der Velde, A., Fan, K., Tsuji, J., Moore, J. E., Purcaro, M. J., Pratt, H., & Weng, Z. (2021) · Communications Biology · doi:10.1038/s42003-021-01756-4 · Cited by 68
Park, S. H., Fong, K.-W., Kim, J., Wang, F., Lü, X., Lee, Y., Brea, L. T., Wadosky, K. M., Guo, C., Abdulkadir, S. A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe2261 · Cited by 78
Neuronal maturation and axon regeneration: unfixing circuitry to enable repair
Hilton, B. J., Griffin, J. M., Fawcett, J. W., & Bradke, F. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00849-3 · Cited by 81
Feng, H., Yu, Z., Tian, Y., Lee, Y., Li, M. S. M., Go, M. Y. Y., Cheung, Y. S., Lai, P. B. S., Chan, A. M.-L., To, K., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.040 · Cited by 75
Epigenetic Modifications of Stem Cells
Zhou, Y., Kim, J., Yuan, X., & Braun, T. W. (2011) · Circulation Research · doi:10.1161/circresaha.111.243709 · Cited by 75
ABCB 1 and ABCG 2 restrict the brain penetration of a panel of novel EZH 2‐Inhibitors
Zhang, P., de Gooijer, M. C., Buil, L. C. M., Beijnen, J. H., Li, G., & van Tellingen, O. (2015) · International Journal of Cancer · doi:10.1002/ijc.29566 · Cited by 75
Mechanisms regulating epidermal stem cells
Beck, B., & Blanpain, C. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.67 · Cited by 75
The Polycomb Complex PRC1: Composition and Function in Plants
Molitor, A. M., & Shen, W. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2012.12.005 · Cited by 74
Principles of nucleation of H3K27 methylation during embryonic developmentPreprint
van Heeringen, S. J., Akkers, R. C., van Kruijsbergen, I., Arif, M. A., Hanssen, L. L. P., Sharifi, N., & Veenstra, G. J. C. (2013) · Genome Research · doi:10.1101/gr.159608.113 · Cited by 76
Mechanisms regulating mammalian spermatogenesis and fertility recovery following germ cell depletion
La, H. M., & Hobbs, R. M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03201-6 · Cited by 77
Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
Li, T., Yu, C., & Zhuang, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.640700 · Cited by 75
Metadata
- Authors
- Margueron, R., & Reinberg, D.
- Affiliations
- Institut Curie (FR)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Reinberg, Danny
- Venue
- Nature
- Published
- 2011-01-19
- Volume
- 469
- Issue
- 7330
- Pages
- 343-349
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3760771
- OpenAlex
- W2060608189
- Cited by
- 3,347
- References
- 97
- Citations by year
- 2026: 145 · 2025: 188 · 2024: 231 · 2023: 211 · 2022: 236 · 2021: 274 · 2020: 260 · 2019: 260 · 2018: 214 · 2017: 236 · 2016: 221 · 2015: 220 · 2014: 202 · 2013: 207 · 2012: 177
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of General Medical Sciences (R37GM037120, R01GM064844)
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- polycomb repressive complex 2, Polycomb group proteins, histone H3 lysine 27 methylation, chromatin condensation, gene expression regulation, cell identity, stem cell plasticity, non-coding RNA, chromatin structure
- MeSH terms
- Animals, Cell Differentiation, Chromatin, Histones, Humans, Methylation, Neoplasms, Histone-Lysine N-Methyltransferase, Repressor Proteins, Genome, Evolution, Molecular, Polycomb-Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review